Veracyte Inc (VCYT NASDAQ) stock market data APIs
$36.3064
-0.63(-1.7%)
as of February 6, 2026
Try our APIs with
free plan!
Veracyte Inc Financial Data Overview
Price chart is built with
Anychart
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Prev. Close
36.3064
Open
35.6795
High
36.3979
Low
34.8047
52 wk Range
22.61-50.71
Market Cap
2 861 M
P/E Ratio
95.2368
Shares Outstanding
79 049 K
Revenue
495 M
EPS
0.51
Beta
1.913
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Veracyte Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Veracyte Inc data using free add-ons & libraries
Get Veracyte Inc Fundamental Data
Veracyte Inc Fundamental data includes:
- Net Revenue: 495 M
- EBITDA: 73 698 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-04
- EPS/Forecast: 0.32
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Veracyte Inc News
New
Here's How Quest Diagnostics Is Placed Ahead of Q4 Earnings
Quest Diagnostics DGX is set to release fourth-quarter 2025 results on Feb. 10, before the market opens. The renowned diagnostics provider posted adjusted earnings per share (EPS) of $2.60 in the las...
Mettler-Toledo (MTD) Q4 Earnings and Revenues Beat Estimates
Mettler-Toledo (MTD) came out with quarterly earnings of $13.36 per share, beating the Zacks Consensus Estimate of $12.76 per share. This compares to earnings of $12.41 per share a year ago. These fig...
Cigna Q4 Earnings Beat Estimates on Higher Specialty Volumes
The Cigna Group CI reported fourth-quarter 2025 adjusted earnings per share (EPS) of $8.08, which beat the Zacks Consensus Estimate by 2.7%. The bottom line advanced 22% year over year. Adjusted reve...
DXCM Upgrades Stelo With AI-Powered Smart Meal Logging Features
Dexcom DXCM recently announced an upcoming nationwide rollout of an AI-driven upgrade to its Stelo platform aimed at improving users’ understanding of glucose health and supporting long-term wellnes...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
